<qa>  What is the tolerability, safety profile and pharmacokinetic profile of ARQAdditional treatment cohorts may be enrolled to explore intermediate, higher or lower doses of ARQ 197, as indicated by the tolerability, safety profile, and pharmacokinetic PK profile. 